2019
DOI: 10.1080/01947648.2019.1645541
|View full text |Cite
|
Sign up to set email alerts
|

The Burden of Federalism: Challenges to State Attempts at Controlling Prescription Drug Costs

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2020
2020
2020
2020

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 4 publications
0
1
0
Order By: Relevance
“…These efforts have attracted ERISA preemption challenges. 45 Similarly, states have tried to regulate pharmacy benefit managers (PBMs), which purport to negotiate better prices from drug manufacturers on behalf of plans, but often require pharmacies to accept less than the plan reimbursement rate and then pocket the difference. PBMs have litigated the ERISA preemption issue into a circuit split, now pending before the Supreme Court.…”
Section: Erisa Preemption Reform As Health Reformmentioning
confidence: 99%
“…These efforts have attracted ERISA preemption challenges. 45 Similarly, states have tried to regulate pharmacy benefit managers (PBMs), which purport to negotiate better prices from drug manufacturers on behalf of plans, but often require pharmacies to accept less than the plan reimbursement rate and then pocket the difference. PBMs have litigated the ERISA preemption issue into a circuit split, now pending before the Supreme Court.…”
Section: Erisa Preemption Reform As Health Reformmentioning
confidence: 99%